APA (7th ed.) Citation

AJ, K., S, S., G, R., S, R., BS, V., DBSA, R., . . . D, C. (2026). Nobiletin reprograms cancer cell fate signaling: PI3K/Akt/mTOR-MAPK crosstalk, NF-kB/STAT3 inhibition and chemosensitization. Cellular signalling, 144, 112549. https://doi.org/10.1016/j.cellsig.2026.112549

Chicago Style (17th ed.) Citation

AJ, Kamath, et al. "Nobiletin Reprograms Cancer Cell Fate Signaling: PI3K/Akt/mTOR-MAPK Crosstalk, NF-kB/STAT3 Inhibition and Chemosensitization." Cellular Signalling 144 (2026): 112549. https://doi.org/10.1016/j.cellsig.2026.112549.

MLA (9th ed.) Citation

AJ, Kamath, et al. "Nobiletin Reprograms Cancer Cell Fate Signaling: PI3K/Akt/mTOR-MAPK Crosstalk, NF-kB/STAT3 Inhibition and Chemosensitization." Cellular Signalling, vol. 144, 2026, p. 112549, https://doi.org/10.1016/j.cellsig.2026.112549.